Pediatrics in California

Passy-Muir, Inc. manufactures the Passy Muir® Tracheostomy & Ventilator Swallowing and Speaking Valve, a one-way speaking valve device designed for tracheostomized and ventilator-dependent patients. Invented by patient David Muir, the valve redirects airflow through the vocal folds, mouth, and nose to enable voice production and improved communication. The device is indicated for both adult and pediatric patients and attaches to a standard tracheostomy tube hub or integrates in-line with ventilator circuits. Clinical evidence supports use of the Passy Muir Valve for multiple therapeutic benefits beyond speech: improved swallowing function, enhanced secretion management, improved oxygenation, restored positive airway pressure, weaning support, decannulation facilitation, restored olfaction, infection control, and pediatric speech-language development. The company also offers complementary accessories, filters, and heat-moisture exchangers (HMEs). Passy-Muir manufactures all products in the USA and holds ISO 13485:2016 certification. The company provides comprehensive clinical education through live seminars, webinars, remote in-services, and workshops targeting speech-language pathologists, respiratory therapists, nurses, and other healthcare professionals who care for tracheostomy and ventilator-dependent populations. Patient testimonials and clinical resources are published on-site. Distribution extends to international markets through authorized distributors.

Origin Medical Devices Kft manufactures advanced ventilation systems designed to deliver a paradigm shift in critical care. The company's flagship product line, Panther ventilators, combines ICU-level performance with non-invasive ventilation and high-flow oxygen therapy in a single integrated platform. The Panther 5N is a dedicated non-invasive ventilator with emergency invasive ventilation capability, while the broader Panther family supports neonatal through adult patients across invasive, non-invasive, and high-flow nasal oxygen (HFO2) modalities. Key technological differentiators include a state-of-the-art blower coupled with a patented proportional flow valve, advanced triggering and patient adaptation algorithms, and a proprietary smart trigger system that improves synchrony and reduces work of breathing in both obstructive and variable-leak scenarios. The ventilators are engineered for independence from compressed gas sources, enabling operation in resource-limited settings and pandemic facilities lacking compressed air infrastructure. Integrated patient monitoring includes SpO2 and volumetric capnography. The 3-in-1 platform design consolidates functionality traditionally requiring three separate devices, reducing space, maintenance burden, and total cost of ownership. The system emphasizes intuitive user interface, portability with extended battery life, minimal preventative maintenance, and repair accessibility without specialized tools. Origin's ventilators are positioned as high-performance alternatives to both traditional dual compressed-gas ICU ventilators and dedicated non-invasive platforms, targeting hospitals worldwide seeking cost-effective, versatile respiratory support across care continuum stages.

Playhouse MD is a Los Angeles-based pediatric medical device company founded in 2023 that designs doctor-developed, playful healthcare products for children and families. The company specializes in reimagining essential home-care medical devices by incorporating engaging character designs, light-up features, and accompanying storytelling guides (Playful Prompts) to reduce healthcare anxiety in children. Core product lines include medicine dispensers, nasal aspirators, infrared thermometers, and nail clippers—all designed with pediatric usability and emotional comfort in mind. Founded by Dr. Kaitlin Wiseman, Sydney Wiseman, and Michael Kamins, Playhouse MD emphasizes transforming routine sick-day care moments into engaging, less intimidating experiences through the Playful Pediatrics™ philosophy.

Ceribell develops point-of-care EEG systems for rapid seizure detection and monitoring in critical care settings. The company's flagship product, a portable EEG platform integrated with the CLARITY® AI algorithm, enables bedside detection of seizure activity, including non-convulsive seizures, in ICUs, emergency departments, and neurology units. CLARITY® is FDA-cleared for pediatric and neonatal patients, representing the first and only FDA-cleared seizure detection algorithm for newborns preterm and up. The system delivers 95% sensitivity and 97% specificity for status epilepticus detection with 99.9% negative predictive value. Ceribell's secure cloud portal features FedRAMP High cybersecurity authorization for telemedicine consultation and remote EEG interpretation. Clinical evidence demonstrates the platform is associated with 4.1-day shorter median ICU stays and improved neurological outcomes compared to conventional EEG workflows. The company supports hospitals with ongoing in-person and virtual training. Target markets include intensive care units, emergency departments, and neurology departments in acute-care hospitals. Ceribell holds multiple FDA clearances (510(k)), CE mark certification, and has published 45+ peer-reviewed publications validating diagnostic accuracy and clinical utility in critical care populations.

Feellife is an international medical nebulization technology company founded in 2009, specializing in the design, manufacture, and distribution of nebulizers, nebulized vaccine equipment, and respiratory care devices. The company operates with facilities in China and the United States and maintains three research institutes: a Nebulization Research Institute, an Institute of Traditional Chinese Medicine, and a dedicated R&D team of 40+ engineers holding 300+ patents. The Feellife product portfolio includes medical nebulizers (Air Pro, Air Kids, Air Mask, Air Flow series), portable and stationary models, spirometers (Air Smart series), breathing trainers (AirFit series), and oxygen concentrators (AirBar Pro). The company also manufactures proprietary Nebu-Dosing™ packaging systems including blow-fill-seal (BFS) technology, octopus ampoules, PET and plastic bottles, and aluminum containers in sizes ranging from 1 mL to 200 mL. Feellife's AiMesh® technology represents a proprietary formulation approach. The company serves hospitals, clinics, and personal users globally and has received multiple certifications including MDR (Medical Device Regulation) certification for 78 products. Industry recognition includes HCA Hospital Partnership of the Year, French Design Award (Gold), International Design Award (Gold), and MedTech Outlook Top 20 Medtech Provider designation. Manufacturing and service capabilities include full R&D, production, sales, and technical support. The company operates manufacturing facilities in multiple locations including Shenzhen's Songgang and Huangtian districts.

Piccolo Medical designs and manufactures guidance systems for peripherally inserted central catheter (PICC) and central venous catheter (CVC) placement. The company's flagship products—PM2+™ System and ECGuide®—use intravascular electrocardiogram (ECG) technology combined with ionic dilution sensing to enable bedside confirmation of catheter tip positioning, eliminating the need for post-placement chest X-ray confirmation. The PM2+™ System features the Nav+™ stylet with machine learning-powered navigation feedback delivered via a mobile app; setup takes under 90 seconds and provides real-time guidance during catheter insertion. ECGuide® is cleared for use in adult, pediatric, and neonatal patients and has been shown to improve placement accuracy and reduce complications including thrombosis and malposition. The technology addresses a significant clinical and operational problem: approximately 50% of PICCs placed without guidance are malpositioned, requiring confirmatory imaging that adds cost, radiation exposure, and procedure time (average 78-minute wait for chest X-ray). Piccolo Medical is FDA 510(k) cleared and has received funding from the National Institute on Aging (NIA) and other federal agencies. The company serves hospitals and healthcare systems focused on improving catheter placement safety and reducing procedural delays.

Aspect Imaging

Aspect Imaging Ltd. is a global leader in the design and development of compact, high-performance MRI systems, utilizing advanced permanent magnet technology for preclinical research and medical applications, especially in neonatal care. Based in Nashville, Tennessee, the company employs around 641 people and generates approximately $20.4 million in revenue. Their focus is on making MRI systems more affordable, easier to install, operate, and maintain compared to traditional high-field superconducting systems. The company offers two main product lines: the Preclinical M-Series, which provides compact, one-touch MRI systems for high-resolution imaging in various research fields, and the Clinical Embrace® Neonatal MRI System, designed for use in Neonatal Intensive Care Units (NICUs) to perform neuroimaging on critically ill infants without the need for transport. Aspect Imaging also collaborates with Brightonix Imaging to offer the SimiPET Simultaneous Preclinical PET/MRI Insert and provides virtual experiences like the M-Series Virtual Lab. Their solutions are utilized by leading healthcare organizations, including Yale New Haven Children’s Hospital and Boston Hospital, showcasing their commitment to advancing neonatal and research imaging.

Woddle Baby Inc. manufactures the Woddle Smart Changing Pad, an FDA-registered Class I medical device that integrates multiple infant care functions into a single smart platform. The device combines a changing pad with built-in scale for weight tracking, adjustable night light, heating pad, sound machine, and touchscreen interface. It syncs with the Woddle Baby mobile app to log feeding, diaper changes, sleep, and weight data in real time, providing parents with continuous monitoring and growth tracking between clinical checkups. The system is designed to support early childhood health monitoring and parental confidence during the critical first months of infancy.

The Kahen Group is a B2C/B2B distributor and retailer of personal hygiene and incontinence consumables, operating an e-commerce platform specializing in diapers, incontinence products, and menstrual care items. The company distributes multiple branded product lines including Geffen Bamboo Baby Diapers (newborn through size 3, eco-friendly bamboo construction), Prevail Incontinence products (bladder control pads for women in various absorbency levels, bariatric briefs for men and women), and Avail organic menstrual pads and period underwear (made from 100% organic cotton). Product offerings span infant diapers, adult incontinence protection, and feminine hygiene products designed for sensitive skin and various absorbency requirements. The company operates a Shopify-based e-commerce store with inventory across multiple SKUs, international shipping capabilities (Australia, Canada, UK, EU, Asia-Pacific), and domestic US delivery. Marketing emphasizes eco-friendly materials, hypoallergenic formulations, and rash-free/comfort-focused positioning. No manufacturing operations, regulatory credentials, or B2B institutional sales information is visible on the website.

Sprig Oral Health Technologies is a specialized dental manufacturer focused on pediatric restorative solutions. The company designs and manufactures zirconia crowns (EZCrowns), mineral trioxide aggregate (MTA) products (SmartMTA and SmartMTA Capsule), and related pediatric dental instruments. EZCrowns are hand-finished, esthetic zirconia restorations engineered for pediatric patients, marketed as the world's first pediatric zirconia crown. SmartMTA products are endodontic materials available in bulk and capsule formats. Sprig serves pediatric dental practices, dental residency programs, and international markets. The company offers hands-on training through Sprig University, a workshop series covering pediatric zirconia crown placement techniques, held in multiple locations globally (Sydney, Chicago, Naples, Las Vegas). Private in-person residency trainings (four-hour programs) are also available. Products are marketed directly through their e-commerce platform (store.sprigusa.com) and internationally via a dedicated sales channel. The company positions itself as a provider of safer, healthier alternatives for pediatric oral health with emphasis on esthetic outcomes and clinical education.

Renata Medical is a MedTech startup headquartered in Newport Beach, California, specializing in minimally invasive medical devices for pediatric cardiology. Founded in 2019, the company develops innovative solutions to address unmet clinical needs in congenital heart disease and pediatric vascular stenosis. The flagship product, Minima Growth Stent System, is the first and only FDA-approved stent designed specifically for infants weighing over 1.5 kg. This breakthrough device features a gradual re-expansion mechanism that accommodates a child's growth from infancy through adulthood, eliminating the need for multiple interventional procedures. Minima represents a transcatheter alternative to traditional open-heart surgery, reducing operative burden while improving long-term outcomes in the neonatal and pediatric population. Renata Medical's leadership comprises experienced professionals with deep expertise in transcatheter devices and pediatric cardiology, ensuring clinically relevant product development and market deployment strategies.

Baby Health Care, Inc. manufactures and distributes BabySmile brand infant health monitoring and respiratory care devices for direct-to-consumer and retail markets. The company produces two primary product categories: motion sensors for SIDS (Sudden Infant Death Syndrome) monitoring and electric nasal aspirators for pediatric nasal congestion relief. The Baby Motion Sensor (E-202) is a wearable device that monitors infant sleep movement and breathing, alerting parents to potential cessation of movement. The BabySmile Electric Nasal Aspirator line includes the full-size S-504 model with hospital-grade suction power for clearing nasal mucus, and the portable S-303 for on-the-go use. Products are designed under medical supervision and carry endorsements from pediatricians and pediatric specialists including board-certified physicians in allergy and immunology. The company emphasizes ease of use, safety (soft silicone tips), hygiene (removable and washable components), and clinical efficacy in preventing secondary infections such as otitis media and supporting infant sleep quality. Products are sold direct via the company website, Amazon, and third-party retailers. The company claims trusted adoption by over one million parents.

PyrAmes Inc develops innovative non-invasive, continuous blood pressure monitoring solutions for patients across all age groups. The company specializes in wireless, calibration-free platforms designed to eliminate the need for invasive arterial lines and improve BP measurement accuracy in critical care settings. Product platforms include: - Boppli®: FDA 510(k)-cleared continuous non-invasive BP monitoring for neonatal and pediatric patients in NICU/PICU environments. Clinical evidence published in peer-reviewed journal Neonatology demonstrates accuracy comparable to arterial lines with superior usability and safety profile. - Bosimi®: Continuous non-invasive BP monitoring system for adult inpatient and emergency department care, enabling real-time hemodynamic assessment without invasive instrumentation. - Bosimi@Home™: Home-based platform for BP diagnostics, treatment validation, and medical management, supporting chronic disease monitoring and hypertension control in ambulatory settings. PyrAmes addresses significant clinical gaps: over 50% of NICU admissions could benefit from continuous BP monitoring but currently receive only intermittent cuff measurements or invasive arterial lines due to cost and safety concerns. In adults, hypertension affects 50% of the US population and contributes to 7.6 million deaths annually worldwide, creating demand for non-invasive continuous monitoring solutions. The company holds FDA 510(k) clearance for Boppli, FDA Breakthrough Device Designation, and recognition from the American Heart Association and National Institutes of Health (NIH RADx Tech Maternal Health Challenge). PyrAmes is a founding member of the CDC National Hypertension Control Roundtable. The technology enables early detection of hemodynamic instability in vulnerable populations including preterm infants and hypertensive adults.

Nihon Kohden OrangeMed, LLC is a US-based manufacturer and distributor of advanced mechanical ventilation systems for neonatal, pediatric, and adult patients. The company's core product portfolio includes the NKV-330, NKV-440, and NKV-550 ventilator series—turbine-driven platforms designed for comprehensive respiratory support across invasive ventilation, non-invasive ventilation, and high-flow oxygen therapy. All primary products have received FDA 510(k) clearance for US market distribution. Key clinical features include HEPA-filtered integrated turbines for protection of both patients and clinicians, Protective Control® technology enabling remote ventilator adjustments from outside isolation rooms, intra-hospital transport portability with hot-swappable batteries, and connectivity to electronic medical records systems via patient data management integration. The Protective Control® interface is particularly designed for infection control in isolation settings, allowing clinicians to monitor and adjust ventilator parameters without direct exposure to potentially contagious patients. The company emphasizes seamless patient transitions between ventilation modes and provides individualized care planning tools through an intuitive, app-based graphical user interface. Nihon Kohden OrangeMed serves hospitals, ICUs, emergency departments, and neonatal/pediatric facilities across North America through regional distributor networks. Technical and clinical support are available Monday–Friday, 8:00 am–5:00 pm Pacific Time.

Masimo Corporation is a global leader in noninvasive patient monitoring solutions, specializing in innovative pulse oximetry, vital sign monitoring, and brain function monitoring technologies. Founded on breakthrough accuracy in pulse oximetry (Masimo SET®), the company develops and manufactures continuous monitoring systems for hospitals, ICUs, operating rooms, and neonatal care settings. Core product lines include Masimo SET® Pulse Oximetry for continuous, accurate oxygen saturation measurement across all patient populations and clinical settings; SedLine® Brain Function Monitoring for depth-of-anesthesia and sedation monitoring; Masimo O3® Regional Oximetry for tissue oxygenation assessment with FDA-cleared hemoglobin parameters; and Root® Patient Monitoring and Connectivity Platform, a modular hospital automation system integrating vital signs, connectivity, and clinical workflow solutions. Masimo technologies are deployed across acute care, perioperative, emergency, neonatal, and general floor environments. The company holds over 900 patents globally and serves leading hospitals and healthcare systems in 30+ countries. Known for motion-artifact rejection and performance accuracy across diverse patient populations, Masimo's solutions address clinical needs in congenital heart disease screening, critical care monitoring, anesthesia management, and cost reduction through early patient distress detection. The company emphasizes sustainability and has strategic partnerships with major healthcare technology providers including Philips. Acquired by Danaher in February 2026.

Hazel Health

Hazel Health is a leading provider of virtual physical and behavioral health care for K-12 students, founded in 2015 and based in San Francisco, CA. The company partners with school districts to deliver telehealth services that enhance student health and readiness to learn. Hazel Health addresses significant gaps in pediatric healthcare, particularly in underserved areas, and operates as the largest nationwide provider of school-based telemedicine, serving over 5,000 schools. The company offers on-demand virtual care through a network of licensed pediatric clinicians, therapists, and other healthcare professionals. Services include mental health support such as crisis intervention and therapy, as well as physical health care for common issues like colds, injuries, and allergies. Hazel Health integrates its care with school staff to promote student success, receiving positive feedback from families and providers for its immediate access and support.

Neotech Products LLC is a US-based manufacturer of specialized medical consumables and devices for neonatal intensive care units (NICU), pediatric intensive care units (PICU), and home health settings. Founded 30 years ago by Dr. Arnold Heyman, the company designs and manufactures products that serve mothers, babies, children, and clinical caregivers. Product lines include breast-like pacifiers (Neotech Ninni), breastfeeding assistance devices (Neotech Bridge), skin-friendly adhesive solutions, ECG electrodes with hydrocolloid borders (NeoLead), tubing holders (NeoSnug), suctioning accessories, tracheostomy products, respiratory support devices, telemetry accessories, transilluminators, ocular exam products, and phototherapy-related consumables. Neotech also offers mobile device cleaning products and electrode accessories. All products are manufactured in the USA with emphasis on clinical efficacy and patient comfort. The company operates through direct sales and a network of specialty distributors across the US and internationally. Neotech emphasizes collaboration with inventors and product developers, offering free product development assistance. The organization maintains strong focus on home health applications and pediatric clinical environments. Core competencies include neonatal care, pediatric support, breastfeeding facilitation, and infection control through skin-friendly materials.

InkSpace Imaging is a medical device manufacturer specializing in lightweight, flexible MRI receive coils for diagnostic imaging systems. Founded in 2017 by UC Berkeley professors and a PhD student, the company develops patented thin-film MRI sensor technology that enhances patient comfort and image quality. The company offers FDA-cleared, high-performance flexible MR coils compatible with Siemens Healthieers, GE Healthcare, and Philips scanners. Products include pediatric MRI coils designed for neonates through adolescents, adult coils optimized for MSK, cardiac, abdominal, and spine imaging, and specialized configurations for breast and prostate imaging. Coils feature ultra-lightweight, body-conforming designs with 12–48 channel configurations supporting high acceleration factors, 360-degree coverage, split-access design for rapid patient positioning, and cable routing that avoids direct patient contact. InkSpace Imaging serves pediatric, adult, and veterinary imaging applications.

CareFusion

CareFusion was a medical technology company based in San Diego, California, focused on enhancing patient safety through innovative solutions in medication management and infection prevention. The company specialized in integrating its technologies with hospital information systems to streamline workflows and improve data management. CareFusion's products supported healthcare goals like Meaningful Use by promoting data centralization and interoperability. The company offered a variety of products, including the SmartWorks Platform for medication management, the Alaris System for infusion therapy, and the Infant Flow LP nCPAP System for neonatal respiratory support. Additionally, CareFusion provided surveillance and analytics tools to assist in therapy management and medication adherence. The company targeted hospitals, health systems, and integrated delivery networks, with implementations across multiple global sites. In 2015, CareFusion was acquired by BD (Becton, Dickinson and Company) and now operates as part of BD's broader medical technology offerings.

Telesair, Inc. is a respiratory care company specializing in high-flow oxygen therapy (HFOT) systems. Their flagship product, the Bonhawa High Flow Respiratory Humidifier, is a standalone HFOT device designed by respiratory care experts and clinicians. The Bonhawa system delivers high-flow oxygen with precise temperature control and humidity management across pediatric (2–25 LPM) and adult (10–80 LPM) patient populations. The device provides oxygen delivery ranges of 21–100%, temperature settings of 31°C, 34°C, and 37°C, and maintains constant humidity levels above 33 mg/L. Telesair positions its technology as bridging hospital and home respiratory care environments. The company also supplies accessory consumables, including the AVEA Disposable Expiratory Filter / Water Trap (Vyaire 11790). The organization is founded by respiratory care professionals with extensive backgrounds in ventilation and respiratory health innovation. Product focus centers on clinician-driven design and advanced respiratory therapy solutions for both acute care and home settings.

Thuasne USA, headquartered in Bakersfield, California, is the American subsidiary of the Thuasne Group, a family-owned French medical device manufacturer with 175+ years of heritage. The company specializes in orthopedic braces, orthotic devices, and therapeutic solutions designed to improve mobility and manage musculoskeletal pain. Operating as an integrator of acquired U.S. companies including Lantz Medical, Townsend Design, Quinn Medical, and Corflex Global, Thuasne USA manufactures prescription-grade custom and off-the-shelf orthotic products. Key product lines include the Rebel Reliever and Rebel Ligament knee braces, SLEEQ AP+ back support systems, SpryStep® ankle-foot orthoses (AFO), and custom rehabilitation splinting with static and dynamic motion capabilities. The company also offers medical compression hosiery and specialized orthotic solutions for post-operative recovery, chronic pain management, sports injuries, and pediatric patients. Thuasne USA maintains FDA compliance and PDAC approval, emphasizing quality, innovation, and patient-centric care across orthopedic, neurological, and vascular applications.

Cosmo Robotics Co., Ltd is a South Korean wearable robotics manufacturer specializing in exoskeleton suits and wearable robotic systems for rehabilitation, mobility assistance, and industrial applications. The company develops and manufactures proprietary wearable robot technology domestically and exports globally. Core product lines include the Exoatlet series (EAM, EA2 Pro), pediatric systems (Bambini Kids, Bambini Teens), personal/geriatric assistance (COSuit, EA Personal), and industrial back-support exoskeletons (COSaver Back). The company emphasizes intention recognition technology, natural gait pattern realization, free walking ability expansion, bio-signal-based walking evaluation, and integrated data collection and analysis capabilities. Products address rehabilitation needs across age groups from infants through elderly populations, as well as occupational ergonomics and daily living support. Manufacturing is Korea-based with international distribution networks. The company maintains patents on core exoskeleton technologies and certifications relevant to medical device and wearable robot classifications. Cosmo Robotics positions itself as a leader in the global wearable robotics market with applications spanning clinical rehabilitation, home care, and industrial workplace safety.

Etac AB is a multinational Swedish healthcare company specializing in assistive devices and patient handling equipment for diverse care settings and life stages. The company operates multiple product brands including Convaid, R82 (pediatric), Etac (adult mobility and daily living aids), Molift (patient hoists and transfer solutions), Ki and Axiom (wheelchairs and seating), HoverTech (air-assisted transfer devices), Klaxon (power assists), Star (pressure-redistribution cushions), and Immedia (manual transfer aids). Convaid, the on-file brand, manufactures lightweight pediatric wheelchairs and adaptive strollers designed to promote participation in everyday activities for children with special needs. Product range spans pediatric assistive devices (standing frames, hygiene chairs), patient handling equipment (mobile hoists, slings, transfer devices), wheelchairs (adult and pediatric, highly adaptable), bathroom aids (bathing, showering, toileting), seating solutions (cushions, backs, custom 3D-printed options), and small aids for daily living (ergonomic cooking, eating, dressing aids). The company emphasizes individual customization, safety for both users and caregivers, and dignity in personal care routines. Manufacturing and product development occurs in Scandinavia and the US. Etac maintains own sales entities in major markets and distributor networks across 70+ countries. The company demonstrates commitment to sustainability, including a remanufacturing concept (re:vive) showing 50% emissions savings versus new products.

The Medi-Kid Co. is a manufacturer and distributor of patented pediatric and adult immobilizer splints for arm and leg support. The company specializes in Pedi-Wrap pediatric arm and leg immobilizers and Medi-Wrap adult arm and leg immobilizers, featuring child-friendly prints and designs. Products are designed to provide comfortable, secure immobilization for fractures, sprains, and post-operative care across pediatric and adult patient populations. The company operates as a direct-to-consumer and B2B supplier, offering sizing guidance and competitive product comparisons.

Cognoa is a pediatric behavioral health company developing AI-powered digital diagnostics and therapeutics for early childhood developmental conditions, with a focus on autism spectrum disorder. The company's flagship product, Canvas Dx™, is the first FDA-authorized digital diagnostic aid for autism in children aged 1.5 to 6 years, enabling remote evaluation and rapid diagnosis within days rather than months or years. Canvas Dx combines analysis of parent questionnaires and child behavior video to provide objective, data-driven diagnostic support that reduces diagnostic delays, healthcare costs, and disparities in care access—particularly for underserved and minority populations. The platform has achieved reimbursement coverage through Highmark Insurance and multiple state Medicaid programs. Beyond autism diagnostics, Cognoa is expanding its AI platform to address other pediatric behavioral health conditions including ADHD and anxiety, with a commitment to equitable, early intervention in developmental health assessment and treatment.

Happiest Baby, Inc. is a consumer baby products and parenting education company founded by Dr. Harvey Karp, a pediatrician and author of bestselling parenting guides. The company's flagship product is SNOO, a smart bassinet that uses gentle rocking motions and white noise to soothe infants and promote safe back-sleeping—the first device to receive FDA De Novo authorization for this purpose. SNOO automatically responds to a baby's cries and includes an integrated sleep sack designed to keep infants securely positioned on their backs, reducing SIDS/SUID risk. The company also manufactures complementary sleep products including Sleepea swaddles, organic sleep sacks and sheets, white noise machines (SNOObear, SNOObie), and various SNOO accessories. Happiest Baby operates both direct-to-consumer retail and a rental program for SNOO bassinets. The company offers a mobile app providing parenting guidance, sleep tracking, and customizable SNOO settings. Products are positioned for home use by parents and families. The company has garnered significant media coverage and endorsements from publications including The New York Times, Time, Forbes, Good Housekeeping, and Parents Magazine. Distribution includes direct purchase, rental, certified pre-loved units, and authorized retail partners.

LeoneAmerica Dental Products, Inc. is a dental equipment and consumables manufacturer serving orthodontic, pediatric orthodontic, and sleep medicine markets. The company manufactures direct bonding brackets, archwires, expansion screws, wire, and acrylic products for laboratory and clinical use. Their product portfolio includes the Leaf Expander® Series (orthodontic expansion devices requiring no home activation), the OK Orthodontics for Kids line (pediatric-focused orthodontic products), and intraoral mandibular advancement devices (MAD) for sleep apnea treatment that mechanically advance the lower jaw to address snoring and obstructive sleep apnea. LeoneAmerica also offers 3DLeone Designer, a software solution for digital orthodontic planning and design. The company operates with a stated commitment to quality control and customer service across manufacturing and support functions. Products are distributed through both direct channels to dental practices and through laboratory networks.

Green Sun Medical designs and manufactures non-surgical scoliosis braces for adolescents, specifically the Whisper Brace—a custom-fit, modular orthopedic device engineered to provide corrective spinal forces while prioritizing patient comfort, breathability, and flexibility. Unlike rigid traditional braces, the Whisper Brace uses a multi-ring corrective pressure system and allows normal movement, eating, and thermoregulation, addressing key compliance barriers in pediatric scoliosis treatment. The brace is custom-made from standard modular components that can be adjusted during follow-up visits to accommodate patient growth and optimize corrective force. Green Sun Medical has developed the Whisper Brace Sensor Intelligence Platform, a compliance and progress-tracking system that integrates wearable sensors to monitor brace wear patterns, provide patient motivation, and deliver physician updates for evidence-based treatment adjustments. The company has received over $1.7 million in National Science Foundation funding to advance the sensor platform. Products are designed in consultation with patients, parents, orthotists, surgeons, and scoliosis research experts. The company serves orthopedic practices, pediatric hospitals, and orthotists treating adolescent scoliosis patients. The device represents a significant advancement in non-surgical scoliosis management for a pediatric population historically challenged by treatment adherence.

Tiburon Medical Enterprises is a direct manufacturer specializing in prefabricated orthotic and prosthetic (O&P) devices and supplies. The company offers a comprehensive product portfolio including cervical collars and thoracic orthoses, spinal support systems (LSO, TLSO chairbacks), upper extremity braces and hand splints, lower extremity orthoses (ankle-foot orthoses, knee braces, hip orthoses), and pediatric orthotics. Their RELEAS™ Generation II Splint is a featured product line. Tiburon serves hospitals, clinics, and rehabilitation facilities with direct manufacturing capabilities and component supplies including PVA bags and ROM joints.

Aulisa Medical is a Palo Alto, CA-based medical device company founded in 2012 that develops FDA-cleared, wireless wearable patient monitoring systems for continuous vital sign tracking in clinical and home environments. The company specializes in cloud-based remote monitoring solutions utilizing artificial intelligence to detect inconsistencies in vital sign data and enable early intervention for potentially adverse events. Products are designed for infants, children, and adults across multiple care settings. The Guardian Angel® product line serves as the primary offering, functioning as both a consumer baby monitor and clinical-grade vital sign monitoring device. Applications include monitoring for sleep safety, chronic respiratory diseases (COPD, sleep apnea), cardiac conditions, post-procedure recovery, and aging-in-place scenarios. The company addresses the need to reduce manual vital sign spot-checking burden for both clinicians and caregivers through automated, continuous monitoring with alert capabilities. Aulisa has achieved FDA clearance for its devices and is backed by Silicon Valley venture capital investors. The company operates both direct-to-consumer and hospital/clinical distribution channels, with products available for in-home use and institutional hospital settings.

NeoLight, LLC manufactures specialized medical devices for neonatal intensive care, including brain monitoring, retinal imaging, phototherapy, and developmental support systems. The company's product portfolio addresses critical clinical needs in NICU environments: the nëo™ CFM with aEEG provides cerebral function monitoring to support decision-making in neurological assessment; the ICON™ retinal imaging system with patented Direct Illumination™ technology enables screening for retinopathy of prematurity and other ocular conditions; the Skylife™ Neonatal Phototherapy System delivers spectral power-optimized treatment for neonatal jaundice; and the P.A.L. (Pacifier-Activated Latch) device encourages non-nutritive sucking to promote oral feeding development in preterm and critically ill infants. NeoLight's devices are designed for use in tertiary and secondary neonatal care settings, emphasizing evidence-based clinical outcomes and user-centered design. The company positions itself as a neonatal innovation leader integrating advanced monitoring, diagnostic imaging, and therapeutic technologies to improve developmental outcomes and reduce NICU length of stay.

Teh Lin Prosthetic & Orthopaedic, Inc. is a multinational prosthetics and orthopedic device manufacturer founded in 1960, serving over 50 countries through 100+ branches with 1,000+ experts. The company specializes in customized prosthetic solutions for all levels of amputation, including comprehensive lower limb (knee joints, hip joints, feet joints), upper limb, and pediatric prosthetic systems. Product lines include microprocessor knees, pneumatic knees, hydraulic knees, and mechanical knee joints; hip joints; specialized feet joints; sockets, liners, and accessories; and pediatric-specific prosthetics. The company also manufactures silicone and gel-based SILFIT liners for prosthetic applications. Orthopedic offerings include scoliosis braces (ScoliBrace). Featured products include the C-TK-4PSOIC, A-TGK-5PSOIC, C-RAY-RP1, A-TGK-4P00AW, C-TK-4P02, and C-XTR-X60 prosthetic components. Teh Lin operates a distribution network and maintains TL OLINK+ Fit Centers for prosthetic fitting and training. The company provides comprehensive solutions addressing lower limb, upper limb, and pediatric prosthetic needs for amputees across diverse clinical and functional levels.

Mobi Technologies Inc manufactures consumer-grade personal health monitoring and home care devices distributed through major retail channels including Amazon, Best Buy, Target, and Walmart. The company's product portfolio focuses on homecare diagnostics and connected wellness devices for families, infants, and elderly care. Primary offerings include thermometers (DualScan ear/forehead models with pulse rate monitoring), Wi-Fi-enabled otoscopes for ENT visualization, smart home monitoring cameras (MobiCam line with HD video, two-way audio, night vision, and AI motion detection), medication dispensers with Wi-Fi connectivity, pulse oximeters, emergency alert buttons, and nasal aspirators. Products emphasize ease-of-use, wireless connectivity (Wi-Fi and Bluetooth), mobile app integration, and accessibility for non-clinical users. The company serves 20+ million families and positions products for baby monitoring, elderly care support, and general home health management. Customer service operates Monday–Friday, 8 AM–5 PM PST. Products are retail-focused consumer devices rather than clinical-grade medical equipment; no FDA 510(k), CE mark, or ISO 13485 certifications are mentioned on the site.

ENDOSEMIO Co., Ltd. is a Taiwan-based medical device company specializing in miniaturized endoscopic imaging technology and single-use (disposable) endoscopes. The company focuses on high-resolution, ultra-compact endoscopic systems with tube diameters under 2.2 mm, enabling insertion into neonatal airways and other delicate anatomical spaces. Product offerings include single-use flexible ureteroscopes, neonatal/pediatric bronchoscope imaging kits, wireless endoscope-imaging tracheostomy kits, high-resolution digital otoscope sets, and veterinary imaging solutions. Core technical capabilities include high-definition micro CMOS imaging sensors, color calibration technology, and silicone endoscope tubing. The modular platform design allows accessory customization for different clinical specialties (ENT, urology, pediatrics, neonatology) and veterinary applications. Recent developments include AI-powered ENT endoscopy systems with enhanced mucosal and vascular pattern recognition for early lesion detection. Single-use design eliminates reprocessing labor, reduces cross-infection risk, and improves operating room turnover efficiency. Products are marketed globally at major trade shows (MEDICA, Healthcare Taiwan). The company emphasizes clinical collaboration and user-centered design developed in partnership with healthcare practitioners.